Dr. Ganguly is an Assistant Professor of Pediatrics at the University of Oklahoma Health Sciences Center (OUHSC) and a physician-scientist at the Center for Pregnancy and Newborn Research (CPNR). Dr. Ganguly is pursuing thematic and innovative research projects exploring the factors affecting the health and disease of newborns, starting before and during pregnancy and continuing well after birth to address important questions regarding fetal origins of juvenile and adult diseases.
MyNCBI Publications Link
Fun Fact: "I was in a cover band named “BPD” with three other doctors."
Medical School: NRS Medical College & Hospital, Kolkata, West Bengal, India
Residency: Jackson Memorial Hospital - University of Miami, Flordia
Fellowship: Rainbow Babies & Children's Hospital - Case Western Reserve University, Cleveland, Ohio
Board-certified for General Pediatrics, American Board of Pediatrics
Board-certified for Neonatal-Perinatal Medicine
The overall goal of the Ganguly lab is to explore the redox regulation of disordered lung development and its effect on neonatal health and disease. As part of a multidisciplinary and diverse group of scientists at the Center for Pregnancy and Newborn Research (CPNR), Dr. Ganguly and his laboratory is invested in developing a basic understanding of how different components of the preterm developing lung interact with each other and with the surrounding environment under the various conditions of neonatal health and disease. His lab strives to promote scientific rigor, team science, and adopting new techniques to increase the resolution for dissecting differences on a cellular, transcriptional, proteomic, and epigenetic level and have a dramatic impact on the understanding of redox plasticity and regulation in the developing lung. He has a keen interest in understanding how interventions such as supplemental oxygen and different types of ventilation affect preterm lungs to cause pulmonary morbidities such as bronchopulmonary dysplasia (BPD), asthma, and airway hyperreactivity. The current project in the lab is engaged in advancing the knowledge of sulfide signaling in the developing lung to uncover novel redox targets for future therapies for hyperoxia-induced BPD and long-term airway remodelling.
Select Honors & Accomplishments:
2018 - 2019: William Randolph Hearst research fellow in Neonatology, Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, OH, USA
2019: Travel award for Pediatric Academic Society 2019, Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, OH, USA
2018: Program representative for the NICHD Clinician Scientist Investigators Meeting, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Potomac, MD, USA
2018: Travel award for the 92nd Perinatal and Developmental Medicine Symposium, Academy of Pediatrics (AAP), Aspen, CO, USA
2018: Travel award & finalist, 5th Annual Neonatal Cardiopulmonary Biology: Young investigator Forum, Chicago, IL, USA
2004: Scholastic award, West Bengal Board of Higher Secondary Education, Kolkata, West Bengal, India
Ganguly A, Ofman G, Vitiello PF. Hydrogen Sulfide-Clues from Evolution and Implication for Neonatal Respiratory Diseases. Children (Basel). 2021 Mar 11;8(3):213. doi: 10.3390/children8030213. PMID: 33799529; PMCID: PMC7999351.
Ganguly A, Martin RJ. Vulnerability of the developing airway. Respir Physiol Neurobiol. 2019 Dec;270:103263. PubMed PMID: 31386914.
- Ganguly A, Makkar A, Sekar K. Volume Targeted Ventilation and High Frequency Ventilation as the Primary Modes of Respiratory Support for ELBW Babies: What Does the Evidence Say?. Front Pediatr. 2020;8:27. PubMed PMID: 32117833; PubMed Central PMCID: PMC7025474.